Korean J Med.  1997 Dec;53(6):853-859.

A Case of Thyrotropin - Secreting Pituitary Adenoma with Normal alpha-subunit / TSH Molar Ratio

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Chung Ang University, Seoul, Korea.

Abstract

Thyrotropin(TSH)-secreting pituitary adenoma is a rare disorder causing hyperthyroidism, which is one of the syndrome of inappropriate secretion of TSH. It is characterized by high serum T4, T3 as well as elevated serum TSH. Generally serum free alpha-subunit concentration is also increased and alpha- subunit/TSH molar ratio is more than 1. This alpha- subunit/TSH molar ratio is a clue of diagnosis as well as a useful marker of therapeutic response. We experienced a case of 29-years old man with hyperthyroidism due to TSH-secreting pituitary adenoma. He was underwent 1.5cm sized pituitary tumor removal via transsphenoidal approach in our neurosurgery department. In immunohistochemical stain monotonous tumor cells showed strong positive reaction to antihuman TSH antibody and equivocal reaction to ACTH antibody. After operation, goiter size was progressively decreased and also serum T4, T3 and TSH were decreased in nearly normal range. However, he showed elevated serum T4, T3 and TSH after 1 month due to residual tumor. So he received radiation therapy thereafter. In this case the alpha-subunit and alpha-subunit/TSH molar ratio were not increased. So we report a case of TSH-secreting pituitary macroadenoma which had low alpha-subunit/TSH molar ratio with a literature review.

Keyword

TSH-secreting pituitary macroadenoma; alpha-subunit / TSH molar ratio

MeSH Terms

Adrenocorticotropic Hormone
Adult
Diagnosis
Goiter
Humans
Hyperthyroidism
Molar*
Neoplasm, Residual
Neurosurgery
Pituitary Neoplasms*
Reference Values
Thyrotropin*
Adrenocorticotropic Hormone
Thyrotropin
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr